<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a multisystemic immunoinflammatory disease with a wide variety of clinical manifestations, whereas <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> is a local <z:e sem="disease" ids="C0026636" disease_type="Disease or Syndrome" abbrv="">oral disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to examine the distribution of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels in patients with active <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, possible association of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> with nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and neopterin levels, and to characterize the differences between patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and those with <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> in terms of these parameters compared with healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 23 patients with active <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, 25 patients with <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> as positive controls, and 21 healthy subjects were included in this study </plain></SENT>
<SENT sid="3" pm="."><plain>Serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and neopterin levels were measured flourimetrically by HPLC </plain></SENT>
<SENT sid="4" pm="."><plain>Serum nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production was assayed by measuring total <z:chebi fb="95" ids="16301">nitrite</z:chebi> levels with Griess reagent </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Significantly higher <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (12.9+/-3.3 micromol/L) and lower nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (41.5+/-10.9 micromol/L) and neopterin (6.4+/-1.0 nmol/L) levels were observed in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease compared with healthy controls (10.7+/-2.0 micromol/L, 49.7+/-16.2 micromol/L, 8.7+/-2.2 nmol/L, respectively) (p&lt;0.03 for neopterin, p&lt;0.04 for <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>) </plain></SENT>
<SENT sid="6" pm="."><plain>However, <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>, <z:chebi fb="0" ids="15373">biopterin</z:chebi> and neopterin levels and the neopterin/<z:chebi fb="0" ids="15373">biopterin</z:chebi> ratio for <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> patients were not significantly different compared to healthy controls </plain></SENT>
<SENT sid="7" pm="."><plain>A significant positive correlation was observed between serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and serum neopterin/<z:chebi fb="0" ids="15373">biopterin</z:chebi> ratio in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (r=0.975, p&lt;0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In contrast to <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo>, there is a higher prevalence of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> may have deleterious effects on the pathology of <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> by decreasing nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> levels and interfering with the immune system </plain></SENT>
</text></document>